Celsion Announces ThermoDox(R) Preclinical Data Publication and Presentations at Upcoming Scientific Conferences

Data Support Clinical Studies in Bone Cancer Planned for 2011 COLUMBIA, MD, Mar 01, 2011 (MARKETWIRE via COMTEX News Network) -- Celsion Corporation (NASDAQ: CLSN) announced today the publication of data highlighting the preclinical efficacy for ThermoDox(R) with High Intensity Focused Ultrasound (HIFU) as well as the presentation of related research abstracts at two upcoming medical conferences. The article, titled "Localized drug release using MRI-controlled focused ultrasound" by lead author Robert Staruch from Centre for Research in Image-Guided Therapeutics, Sunnybrook Health Sciences Centre, in Toronto, Canada, will be published in the March 2011 issue of the International...

Source:
http://article.wn.com/view/2011/03/01/Celsion_Announces_ThermoDoxR_Preclinical_Data_Publication_an/

cnn news video international news articles 13 news news channel 5 san diego news 8